Citius Pharmaceuticals, Inc.
corporate_fare Company Profile
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for CTXR at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Citius Pharmaceuticals Reports Going Concern, Nasdaq Non-Compliance, and Significant Dilutive Capital Raises
Financial Snapshot
Fiscal year ended September 30, 2025
Net Income
-$39.74M
Diluted EPS
-$3.38
Op. Cash Flow
-$26.55M
Operating Income
-$38.53M
Cash & Equivalents
$4.25M
Debt / Equity
0.00×
Shares Outstanding
18.07M sh
Source: 10-K · filed 2026-01-28 · accession 0001213900-26-008861
show_chartPrice Chart
Loading chart...
feed CTXR - Filings & News (Page 2)
CTXR
Feb 13, 2026, 8:00 AM EST
Price at Filing:
$0.8547
Real-time Price:
$0.5085
Change:
-$0.3462 (-41%)
Market Cap:
$13.96M